[DOI] [PubMed] [Google Scholar] 172.Dbrowska K, Kamierczak Z, Majewska J, Miernikiewicz P, Piotrowicz A, Wietrzyk J, et al
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Better Absorption for Some Individuals: People with certain medical conditions, such as pernicious anemia or gastrointestinal disorders like Crohns disease, might not absorb enough vitamin B12 from food
Smaller is better. It must be able to get into the brain
N.HoxhaE.AllsopS